CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 27(Granted Patents)

Location History:

East Windsor, NJ (US) (2006)
Princeton, NJ (US) (2016)
Cream Ridge, NJ (US) (2009 - 2022)

Company Filing History:

4 out of 2,405

Merck Sharp + Dohme Corp.

Forma Therapeutics, Inc.

patents

4. 1 out of 10

Aratana Therapeutics, Inc.

patents

Years Active: 2006-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11267805 - Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone (2022-03-08),

2. 10793554 - Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone (2020-10-06),

3. 9388186 - Preparation of crystalline forms of dihydropyrazolopyrimidinone (2016-07-12),

4. 9265756 - Crystalline forms of grapiprant (2016-02-23),

5. 8703779 - Preparation of crystalline forms of dihydropyrazolopyrimidinone (2014-04-22),

6. 8129413 - Crystalline forms of MC4R agonist and process for synthesis (2012-03-06),

7. 7700611 - Synthesis and crystalline forms of NPY5 antagonist (2010-04-20),

8. 7629470 - Formation of tetra-substituted enamides and stereoselective reduction thereof (2009-12-08),

9. 7612072 - Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor (2009-11-03),

10. 7022841 - Process for making carbapenem compounds (2006-04-04),

Title: **The Innovative Journey of Inventor Robert Wenslow**

Introduction

Robert Wenslow, a prolific inventor based in Cream Ridge, NJ, has made significant contributions to the field of chemical innovations. With a remarkable portfolio of 10 patents, Wenslow has demonstrated his expertise and dedication to advancing technology and improving existing processes. His work continues to impact the pharmaceutical industry and beyond.

Latest Patents

Wenslow's latest innovations include two noteworthy patents focusing on solid forms of a specific compound, namely:

- Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazine-1-yl)(1-hydroxycyclopropyl)methanone.

- Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazine-1-yl)(1-hydroxycyclopropyl)methanone.

These patents represent important advancements in the formulation and stability of pharmaceutical compounds, showcasing Wenslow's commitment to innovation.

Career Highlights

Throughout his career, Wenslow has gained invaluable experience while working with prominent companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His role in these organizations has allowed him to collaborate on critical projects, further enhancing his expertise in the field of drug development and formulation.

Collaborations

Robert Wenslow has collaborated with talented individuals such as Russell R. Ferlita and Andrey V. Peresypkin. These partnerships have contributed to his successful inventions and the advancement of various projects within the pharmaceutical domain.

Conclusion

Robert Wenslow's journey as an inventor exemplifies the impact of innovation in the pharmaceutical industry. With a solid portfolio of patents and fruitful collaborations, he continues to pave the way for future advancements in drug formulation and delivery. His contributions are a testament to the power of creativity and dedication in driving substantial progress in science and technology.

This text is generated by artificial intelligence and may not be accurate.